| Literature DB >> 26510739 |
Peter Ranger1, Bart A Ellenbroek2.
Abstract
Valproic acid or valproate (VPA) is an anti-convulsant and mood stabiliser effective in treating epilepsy and bipolar disorders. Although in adults VPA is well tolerated and safe, there is convincing evidence that it has teratogenic properties, ranging from mild neurodevelopmental changes to severe congenital malformations. In particular, studies involving humans and other animals have shown that prenatal exposure to VPA can induce developmental abnormalities reminiscent of autism spectrum disorder (ASD). In this chapter, we discuss the connection between VPA and ASD, evaluate the VPA animal model of ASD, and describe the possible molecular mechanisms underlying VPA's teratogenic properties.Entities:
Keywords: ASD; Animal models; Autism; Behaviour; HDAC-I; Oxidative stress; ROS; Teratogen; VPA; Valproate; Valproic Acid
Mesh:
Substances:
Year: 2016 PMID: 26510739 DOI: 10.1007/7854_2015_404
Source DB: PubMed Journal: Curr Top Behav Neurosci ISSN: 1866-3370